These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 21192999)
41. Future of cholesteryl ester transfer protein inhibitors. Rader DJ; deGoma EM Annu Rev Med; 2014; 65():385-403. PubMed ID: 24422575 [TBL] [Abstract][Full Text] [Related]
42. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Drayna D; Jarnagin AS; McLean J; Henzel W; Kohr W; Fielding C; Lawn R Nature; 1987 Jun 18-24; 327(6123):632-4. PubMed ID: 3600759 [TBL] [Abstract][Full Text] [Related]
43. Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure. Guyard-Dangremont V; Tenekjian V; Chauhan V; Walter S; Roy P; Rassart E; Milne AR Protein Sci; 1999 Nov; 8(11):2392-8. PubMed ID: 10595541 [TBL] [Abstract][Full Text] [Related]
44. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636 [TBL] [Abstract][Full Text] [Related]
45. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia. Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236 [TBL] [Abstract][Full Text] [Related]
46. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Kaser S; Ebenbichler CF; Wolf HJ; Sandhofer A; Stanzl U; Ritsch A; Patsch JR Metabolism; 2001 Jun; 50(6):723-8. PubMed ID: 11398152 [TBL] [Abstract][Full Text] [Related]
47. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. de Grooth GJ; Smilde TJ; Van Wissen S; Klerkx AH; Zwinderman AH; Fruchart JC; Kastelein JJ; Stalenhoef AF; Kuivenhoven JA Atherosclerosis; 2004 Apr; 173(2):261-7. PubMed ID: 15064100 [TBL] [Abstract][Full Text] [Related]
48. Mouse monoclonal antipeptide antibodies specific for cholesteryl ester transfer protein (CETP). Thomas AP; Smith AM; Cumming RI; Jones C; Thomas RC; Pleasants KT; Barakat H Hybridoma; 1996 Oct; 15(5):359-64. PubMed ID: 8913785 [TBL] [Abstract][Full Text] [Related]
49. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713 [TBL] [Abstract][Full Text] [Related]
50. Vaccines for cholesterol management. Rittershaus CW World J Surg; 2007 Apr; 31(4):690-4. PubMed ID: 17347898 [TBL] [Abstract][Full Text] [Related]
51. Progress and future opportunities in the development of vaccines against atherosclerosis. Govea-Alonso DO; Beltrán-López J; Salazar-González JA; Vargas-Morales J; Rosales-Mendoza S Expert Rev Vaccines; 2017 Apr; 16(4):337-350. PubMed ID: 27817213 [TBL] [Abstract][Full Text] [Related]
55. Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite. Braga Emidio N; Meli R; Tran HNT; Baik H; Morisset-Lopez S; Elliott AG; Blaskovich MAT; Spiller S; Beck-Sickinger AG; Schroeder CI; Muttenthaler M J Med Chem; 2021 Jul; 64(13):9484-9495. PubMed ID: 34142550 [TBL] [Abstract][Full Text] [Related]
56. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice. Zhu L; He Z; Wu F; Ding R; Jiang Q; Zhang J; Fan M; Wang X; Eva B; Jan N; Liang C; Wu Z Cardiovasc Diabetol; 2014 Nov; 13():151. PubMed ID: 25391642 [TBL] [Abstract][Full Text] [Related]
57. Production of a plant-derived immunogenic protein targeting ApoB100 and CETP: toward a plant-based atherosclerosis vaccine. Salazar-Gonzalez JA; Rosales-Mendoza S; Romero-Maldonado A; Monreal-Escalante E; Uresti-Rivera EE; Bañuelos-Hernández B Mol Biotechnol; 2014 Dec; 56(12):1133-42. PubMed ID: 25143122 [TBL] [Abstract][Full Text] [Related]
58. A chimeric peptide of intestinal trefoil factor containing cholesteryl ester transfer protein B cell epitope significantly inhibits atherosclerosis in rabbits after oral administration. Qi G; Li J; Wang S; Xin S; Du P; Zhang Q; Zhao X Peptides; 2011 Apr; 32(4):790-6. PubMed ID: 21192999 [TBL] [Abstract][Full Text] [Related]
59. Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis. Mao D; Kai G; Gaofu Q; Zheng Z; Li Z; Jie W; Jingjing L; Rongyue C Vaccine; 2006 Jun; 24(23):4942-50. PubMed ID: 16697088 [TBL] [Abstract][Full Text] [Related]
60. Co-administration of a CpG adjuvant (VaxImmune, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice. Thomas LJ; Hammond RA; Forsberg EM; Geoghegan-Barek KM; Karalius BH; Marsh HC; Rittershaus CW Hum Vaccin; 2009 Feb; 5(2):79-84. PubMed ID: 18670196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]